Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

The Study of GW493838, an Adenosine A1 Agonist, in Peripheral Neuropathic Pain

ClinicalTrials.gov ID: NCT00376454

Public ClinicalTrials.gov record NCT00376454. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Tolerability of a 14 Day Treatment Course of GW493838 50mg Compared to Placebo in Subjects With Peripheral Neuropathic Pain

Study identification

NCT ID
NCT00376454
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
113 participants

Conditions and interventions

Interventions

  • GW493838 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2002
Primary completion
May 31, 2003
Completion
May 31, 2003
Last update posted
Feb 11, 2013

2002 – 2003

United States locations

U.S. sites
32
U.S. states
20
U.S. cities
31
Facility City State ZIP Site status
GSK Clinical Trials Call Center Huntsville Alabama 35801
GSK Clinical Trials Call Center Hot Springs Arizona 71913
GSK Clinical Trials Call Center Little Rock Arkansas 72205
GSK Clinical Trials Call Center La Jolla California 92037
GSK Clinical Trials Call Center Oceanside California 92056
GSK Clinical Trials Call Center Boulder Colorado 80304
GSK Clinical Trials Call Center Fort Lauderdale Florida 33308
GSK Clinical Trials Call Center Fort Myers Florida 33916
GSK Clinical Trials Call Center Palm Beach Florida 33409
GSK Clinical Trials Call Center Palm Beach Gardens Florida 33410
GSK Clinical Trials Call Center Pembroke Pines Florida 33024
GSK Clinical Trials Call Center South Daytona Florida 32119
GSK Clinical Trials Call Center St. Petersburg Florida 33701
GSK Clinical Trials Call Center West Palm Beach Florida 33407
GSK Clinical Trials Call Center Evansville Indiana 47712
GSK Clinical Trials Call Center Lexington Kentucky 40503
GSK Clinical Trials Call Center Louisville Kentucky 40202
GSK Clinical Trials Call Center Louisville Kentucky 40205
GSK Clinical Trials Call Center Covington Louisiana 70433
GSK Clinical Trials Call Center Boston Massachusetts 02115
GSK Clinical Trials Call Center Henderson Nevada 89052
GSK Clinical Trials Call Center Lebanon New Hampshire 03766
GSK Clinical Trials Call Center Ridgewood New Jersey 07450
GSK Clinical Trials Call Center Albany New York 12205
GSK Clinical Trials Call Center Asheville North Carolina 28803
GSK Clinical Trials Call Center Winston-Salem North Carolina 27103
GSK Clinical Trials Call Center Tulsa Oklahoma 74104
GSK Clinical Trials Call Center Altoona Pennsylvania 16601
GSK Clinical Trials Call Center Duncansville Pennsylvania 16635
GSK Clinical Trials Call Center Richardson Texas 75080
GSK Clinical Trials Call Center Tacoma Washington 98405
GSK Clinical Trials Call Center Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00376454, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 11, 2013 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00376454 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →